Research shows that vitamin B2 levels before chemotherapy may predict which colorectal cancer patients will experience severe side effects from the drug capecitabine. A 2026 prospective cohort study of 297 patients found that higher B2 concentrations were associated with 19% lower risk of treatment-limiting side effects, while higher glycine levels nearly doubled the risk. Folate’s protective effect depended on patients’ genes. These findings suggest blood nutrient testing might eventually help doctors predict and prevent chemotherapy side effects, though more research is needed before changing clinical practice.
Researchers studied 297 colorectal cancer patients undergoing chemotherapy to understand how B vitamins and related nutrients affect treatment side effects. According to Gram Research analysis, certain B vitamins—particularly B2—were linked to fewer severe reactions to the cancer drug capecitabine. The study also found that genetic differences affect how folate (a B vitamin) protects against side effects. These findings suggest that measuring a patient’s vitamin levels before treatment might help doctors predict who will struggle with medication side effects and potentially adjust care accordingly.
Key Statistics
A 2026 prospective cohort study of 297 colorectal cancer patients found that 53% experienced chemotherapy side effects severe enough to require treatment modifications, with vitamin B2 levels showing a protective association reducing risk by 19% for each doubling of concentration.
According to research reviewed by Gram, higher glycine concentrations in colorectal cancer patients were associated with an 87% increased risk of severe chemotherapy side effects, while vitamin B2 showed the opposite protective pattern.
In the 2026 study of 297 patients, folate’s protective effect against chemotherapy toxicity depended on genetic variation—reducing risk by 25% in patients with CT/TT MTHFR genotypes but not in those with CC genotypes.
Among 297 colorectal cancer patients receiving capecitabine chemotherapy, homocysteine, methionine, and serine showed no significant association with treatment side effects, suggesting selective rather than universal importance of one-carbon metabolism nutrients.
The Quick Take
- What they studied: Whether B vitamins and related nutrients in the blood can predict which cancer patients will experience severe side effects from chemotherapy
- Who participated: 297 patients with stage II-III colorectal cancer who were receiving a chemotherapy drug called capecitabine as part of their cancer treatment
- Key finding: Vitamin B2 levels were protective—patients with higher B2 had 19% lower risk of severe side effects. However, higher glycine (an amino acid) was linked to nearly double the risk of problems. Folate’s protective effect depended on a patient’s genes.
- What it means for you: If you’re starting this type of chemotherapy, your doctor might eventually be able to test your B vitamin levels to predict side effects. This is early research, so don’t change your vitamin intake without medical guidance—too much can also cause problems.
The Research Details
Researchers followed 297 colorectal cancer patients who were receiving chemotherapy treatment. Before treatment started, they drew blood samples and measured eight different nutrients related to one-carbon metabolism—a biochemical process that the chemotherapy drug targets. They also identified each patient’s genetic variation in a gene called MTHFR, which affects how the body processes folate. Over the course of treatment, researchers tracked which patients experienced severe side effects serious enough to require dose reductions or treatment delays.
The researchers used statistical methods to look for patterns between nutrient levels and side effects. They examined whether the relationship was straight-line (more nutrient = less risk) or curved (where very high or very low levels might be problematic). They also checked whether genetic differences changed these patterns.
This approach is important because chemotherapy side effects are a major problem—they can force doctors to reduce doses or stop treatment, which might reduce cancer-fighting effectiveness. If doctors could predict who will have severe side effects based on a simple blood test, they might be able to adjust nutrition or treatment plans beforehand. Understanding the role of B vitamins is particularly relevant because these are nutrients people can potentially modify through diet or supplements.
This was a prospective study, meaning researchers followed patients forward in time rather than looking backward at medical records—this is stronger evidence. The study included a substantial number of patients (297) and measured multiple nutrients carefully. However, the study was observational, so it shows associations but cannot prove that low B vitamins cause side effects. The researchers adjusted for age and sex but couldn’t account for all possible factors like diet quality or other medications. Results for folate depended heavily on genetic type, suggesting findings may not apply equally to everyone.
What the Results Show
More than half of the patients (53%, or 156 out of 297) experienced side effects severe enough to require changes to their chemotherapy treatment. Vitamin B2 showed the clearest protective effect: for every doubling of B2 concentration in the blood, the risk of severe side effects dropped by 19%. This relationship held true across the entire patient population regardless of genetics.
Folate (another B vitamin) showed a more complicated pattern. In patients with a specific genetic variation (CT or TT type of the MTHFR gene), higher folate was protective—reducing risk by 25% for each doubling of folate levels. However, in patients with the CC genetic type, higher folate actually appeared to increase risk slightly, though this finding was less certain. This demonstrates that genetic differences matter significantly for how nutrients affect treatment tolerance.
Glycine, an amino acid involved in one-carbon metabolism, showed the opposite pattern of B2. Higher glycine concentrations were associated with nearly double the risk of severe side effects (87% increased risk). Vitamin B6 and B12 showed nonlinear relationships, meaning the risk didn’t change in a simple straight-line pattern with nutrient levels.
Homocysteine, methionine, and serine—three other molecules in the one-carbon metabolism pathway—showed no clear association with side effects. This suggests that not all nutrients in this metabolic pathway equally influence chemotherapy tolerance. The findings indicate that the relationship between nutrition and chemotherapy side effects is selective and complex, with some nutrients mattering more than others.
Previous research has shown that one-carbon metabolism is important for how the body processes capecitabine chemotherapy. This study is among the first to systematically examine multiple nutrients in this pathway and their connection to actual side effects in patients. The finding that B2 is protective aligns with its known role in energy metabolism and detoxification. The genetic differences in folate’s effect match what scientists understand about how the MTHFR gene influences folate metabolism, lending credibility to the findings.
This study followed patients receiving treatment but couldn’t randomly assign them to different nutrient levels, so it cannot prove that low B vitamins cause side effects—only that they’re associated. The study didn’t measure patients’ actual diets, so researchers couldn’t determine whether nutrient levels came from food or supplements. Results were strongest for B2 and glycine but weaker for other nutrients, suggesting some findings may have occurred by chance. The study included mostly one type of cancer patient at one treatment stage, so results may not apply to other cancer types or earlier/later disease stages. Finally, the study didn’t test whether actually supplementing with B vitamins would reduce side effects.
The Bottom Line
This research is preliminary and not yet ready for clinical practice changes. Patients should not start taking high-dose B vitamin supplements based on this study alone—excessive B vitamins can cause their own problems. However, this research suggests that future studies testing whether optimizing B vitamin levels before chemotherapy could reduce side effects are worthwhile. Patients undergoing capecitabine chemotherapy should discuss their nutrition status with their oncology team. Moderate confidence: B2 appears protective, but more research is needed before making treatment recommendations.
This research is most relevant to patients with stage II-III colorectal cancer who are about to receive capecitabine chemotherapy. Oncologists and cancer nutritionists should be aware of these findings when counseling patients. Patients with other cancer types receiving different chemotherapy drugs should not assume these findings apply to them. People considering B vitamin supplementation for cancer prevention should consult their doctor, as this study doesn’t address prevention in healthy people.
If doctors eventually use nutrient testing to guide treatment, the benefit would be apparent before or during the first few weeks of chemotherapy when side effects typically emerge. However, this is future-focused research—current clinical practice hasn’t yet incorporated these findings.
Frequently Asked Questions
Can B vitamins prevent chemotherapy side effects?
Research suggests vitamin B2 may reduce severe side effects in colorectal cancer patients receiving capecitabine, but this is preliminary. Don’t supplement without medical guidance—excess B vitamins can cause problems. Your oncology team should guide any nutritional changes.
Should I get my B vitamin levels tested before starting chemotherapy?
Current clinical practice doesn’t routinely include this testing yet. However, discussing your nutrition status with your oncology team is wise. Future research may support pre-treatment nutrient testing, but that’s not standard care today.
Does folate help with chemotherapy side effects?
Folate’s effect depends on your genes. In some patients, higher folate reduced side effects by 25%, while in others it showed no benefit. This genetic variation means one-size-fits-all folate recommendations won’t work for everyone.
What foods have vitamin B2 if I’m undergoing cancer treatment?
Good B2 sources include almonds, mushrooms, salmon, eggs, and fortified cereals. However, don’t dramatically increase intake without consulting your oncology team, as nutrient interactions with chemotherapy are complex and individual.
Does this research apply to other types of cancer?
This study focused specifically on stage II-III colorectal cancer patients receiving capecitabine. Results may not apply to other cancer types or different chemotherapy drugs. Always discuss your specific situation with your oncologist.
Want to Apply This Research?
- If you’re undergoing capecitabine chemotherapy, track weekly side effect severity (nausea, hand-foot syndrome, diarrhea) on a 1-10 scale alongside any dietary changes or supplements. Note dates when your oncologist adjusted your dose due to side effects.
- Work with your oncology team to document your baseline B vitamin intake through diet (eggs, whole grains, leafy greens, fish). If future research supports it, you might adjust intake before treatment starts—but only under medical supervision, as excess B vitamins can interfere with some treatments.
- Create a pre-treatment nutrition snapshot: document your typical weekly intake of B2-rich foods (almonds, mushrooms, salmon), folate sources (spinach, lentils, asparagus), and B6 sources (chickpeas, bananas, chicken). Share this with your oncology team. After treatment begins, correlate any severe side effects with your baseline nutrition status to identify patterns.
This research is preliminary and not yet incorporated into standard cancer care. Do not change your B vitamin intake or supplement regimen based on this study without explicit guidance from your oncology team. B vitamin supplements can interact with chemotherapy drugs and other medications. If you are undergoing or about to undergo cancer treatment, discuss all nutritional decisions with your oncologist or registered dietitian specializing in oncology. This article is for educational purposes and should not replace professional medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.